Literature DB >> 2715054

The distribution of GAWK-like immunoreactivity in neuroendocrine cells of the human gut, pancreas, adrenal and pituitary glands and its co-localisation with chromogranin B.

A E Bishop1, K Sekiya, M J Salahuddin, F Carlei, G Rindi, M Fahey, J H Steel, M Hedges, T Domoto, R Fischer-Colbrie.   

Abstract

GAWK is a recently discovered peptide isolated from extracts of human pituitary gland and subsequently shown to be identical to sequence 420-493 of human chromogranin B. The distribution of this peptide was studied in human gut, pancreas, adrenal and pituitary glands using antisera to two portions of the 74 amino acid peptide (sequences 1-17 and 20-38). In addition, the co-existence of GAWK immunoreactivity with other peptides and chromogranin B was investigated using comparative immunocytochemistry. In the gut, GAWK was localised mainly to serotonin-containing cells of the mucosal epithelium, where electron microscopy showed it to be stored in typical electron-dense (250 nm diameter) granules, and to a moderate population of nerve fibres in the gut wall. Considerable quantities of GAWK-like immunoreactivity were measured in the gut, up to 36.3 +/- 18 pmol GAWK 1-17/g wet weight of tissue (mean +/- SEM) and 12.4 +/- 2.9 pmol GAWK 20-38/g. Chromatography of gut extracts revealed several GAWK-like immunoreactive peaks. GAWK-like immunoreactivity was also detected in endocrine cells of pancreas, pituitary gland and adrenal medulla, where the highest concentrations of GAWK-like immunoreactivity were measured (GAWK 1-17 2071.8 +/- 873.2 and GAWK 20-38 1292.7 +/- 542.7 pmol/g). Endocrine cells containing GAWK-like immunoreactivity were found also to be immunoreactive for chromogranin B. Our results define a discrete distribution of GAWK immunoreactivity in human endocrine cells and nerves and provide morphological support for the postulated precursor-product relationship between chromogranin B and GAWK. Details of the functions of this peptide are awaited.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715054     DOI: 10.1007/BF00494359

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  25 in total

1.  Presence of chromogranin A, B and C in bovine endocrine and nervous tissues: a comparative immunohistochemical study.

Authors:  H Lassmann; C Hagn; R Fischer-Colbrie; H Winkler
Journal:  Histochem J       Date:  1986-07

2.  Chromogranin: a newly recognized marker for endocrine cells of the human gastrointestinal tract.

Authors:  P Facer; A E Bishop; R V Lloyd; B S Wilson; R J Hennessy; J M Polak
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

3.  Immunological characterization of secretory proteins of chromaffin granules: chromogranins A, chromogranins B, and enkephalin-containing peptides.

Authors:  R Fischer-Colbrie; I Frischenschlager
Journal:  J Neurochem       Date:  1985-06       Impact factor: 5.372

4.  The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin.

Authors:  A L Iacangelo; R Fischer-Colbrie; K J Koller; M J Brownstein; L E Eiden
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

5.  Localization of substance P-like immunoreactivity in mouse gut.

Authors:  G Nilsson; L I Larsson; R Håkanson; E Brodin; B Pernow; F Sundler
Journal:  Histochemistry       Date:  1975

Review 6.  Regulatory peptides: key factors in the control of bodily functions.

Authors:  J M Polak; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-07

7.  Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas.

Authors:  A Ali-Rachedi; I M Varndell; T E Adrian; D A Gapp; S Van Noorden; S R Bloom; J M Polak
Journal:  Histochemistry       Date:  1984

8.  Chromogranin A, B, and C in human adrenal medulla and endocrine tissues.

Authors:  C Hagn; K W Schmid; R Fischer-Colbrie; H Winkler
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

9.  Chromogranin B (secretogranin I), a putative precursor of two novel pituitary peptides through processing at paired basic residues.

Authors:  S Benjannet; R Leduc; N Adrouche; J P Falgueyret; M Marcinkiewicz; N G Seidah; M Mbikay; C Lazure; M Chretien
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

10.  Combined immunostaining of neurofilaments, neuron specific enolase, GFAP and S-100. A possible means for assessing the morphological and functional status of the enteric nervous system.

Authors:  A E Bishop; F Carlei; V Lee; J Trojanowski; P J Marangos; D Dahl; J M Polak
Journal:  Histochemistry       Date:  1985
View more
  4 in total

1.  Ultrastructural identification of human secretin cells by the immunogold technique. Their costorage of chromogranin A and serotonin.

Authors:  L Usellini; G Finzi; C Riva; C Capella; T Mochizuki; C Yanaihara; N Yanaihara; E Solcia
Journal:  Histochemistry       Date:  1990

Review 2.  Gut endocrine and neural peptides.

Authors:  Anne E Bishop; Julia M Polak
Journal:  Endocr Pathol       Date:  1990-03       Impact factor: 3.943

Review 3.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

Review 4.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.